secwatch.observer — SEC 8-K summary
======================================

Issuer:     NRX Pharmaceuticals, Inc. (NRXP)
CIK:        0001719406
Form:       8-K
Filed at:   2025-04-17T23:59:59+00:00
Accession:  0001437749-25-012303
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NRx Pharmaceuticals boosts ATM offering capacity to $20M; previously sold $1.8M
-------------------------------------------------------------------------------

- Maximum aggregate offering price increased to $20,000,000 under ATM agreement with H.C. Wainwright & Co.
- Approximately $1.8 million in common stock sold prior to the increase.
- Prospectus supplement filed on April 17, 2025 to register the additional shares.
- Legal opinion on share validity filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719406/000143774925012303/0001437749-25-012303-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719406/000143774925012303/nrxp20250417_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-012303

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer